close

Enter

Log in using OpenID

Bone Morphogenetic Protein Market

embed
According to a recent market research report published by Transparency Market Research, the global bone morphogenetic protein market is estimated to expand at a CAGR of 2.10% during the period from 2014 to 2022. The report, titled “Bone Morphogeneti
BONE MORPHOGENETIC PROTEIN MARKET: RAPIDLY GROWING GERIATRIC
POPULATION TO BOOST MARKET VALUATION TO US$587.069 MN BY 2022HEADING
A new Transparency Market Research report states that the global bone morphogenetic protein market
was valued at US$612.601 mn in 2013.and is predicted to reach US$587.069 mn by 2022. It is expected to
expand at a sluggish CAGR of 2.10% from 2014 to 2022. The title of the report is “Bone Morphogenetic
Proteins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2022”.
According to the report, the market for bone morphogenetic proteins is fuelled by the growing geriatric
population, increasing sports and trauma injuries, and the increasing count of spinal fusion surgeries. In
addition, the growing demand for minimally invasive surgeries and a rise in population having lower back
pain issues will also augment the demand for bone morphogenetic proteins. On the other hand, factors
such as the presence of a number of other bone graft substitutes and the detrimental side-effects caused
by the off-label usage of bone morphogenetic proteins may impede the growth of the market in the
coming years. Furthermore, the soaring costs of bone morphogenetic proteins may also pose a negative
effect on the growth of the market.
The report segments the market on the basis of type into rhBMP-2 and rhBMP-7. Amongst these, in 2013,
the segment of rhBMP-2 held the largest share in the market on the basis of revenue. This is because
rhBMP-2 has been broadly accepted by surgeons and physicians globally owing to it being effective in
carrying out lower back spinal fusions. On the other hand, the segment of rhBMP-7 is predicted to lose all
of its market share in the forthcoming years owing to the elimination of OP-1/Opgenra from the market,
starting from August 2014.
Get a Sample Report Brochure:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2308
On the basis of application, the report segments the market into trauma, spinal fusion, oral maxillofacial,
and reconstructive surgery. Amongst these, the segment of spinal fusion holds the largest share in the
market, trailed by the segment of trauma. On the other hand, the reconstructive segment is predicted to
expand at low CAGR in the forecast horizon. This is owing to the availability of a number of promising
bone graft alternatives and the limited utilization of bone morphogenetic protein products in
reconstructive surgery.
On the basis of geography, the bone morphogenetic proteins market is segmented into Europe, North
America, Asia Pacific, and Rest of the World (RoW). Amongst these, North America constitutes the largest
share of more than 70% in the market for bone morphogenetic proteins and is predicted to lead the
market all through the forecast horizon. This is due to the increasing awareness on bone morphogenetic
protein products and the rising count of spinal fusion procedures.As per the report, the chief players
operating in the market are Medtronic, Cellumed Co. Ltd., and Stryker Corporation, among others.
The global bone morphogenetic proteins market is segmented as follows:
Global Bone Morphogenetic Proteins Market Revenue, by Types

rhBMP-2

rhBMP-7
Global Bone Morphogenetic Proteins Market Revenue, by Application

Spinal Fusion

Trauma

Reconstructive Surgery

Oral-Maxillofacial
Global Bone Morphogenetic Proteins Market Revenue, by Geography

North America
o
Types
o
Applications

Europe
o
Types
o
Applications

Asia Pacific
o
Types
o
Applications

RoW
o
Types
o
Applications
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business
information reports and services. The company’s exclusive blend of quantitative forecasting and trend
analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants use proprietary data sources and various tools and techniques to
gather and analyze information.
Website: http://www.transparencymarketresearch.com
Author
Priya
Priya45   documents Email
Document
Category
Health and Medicine
Views
6
File Size
270 KB
Tags
morphogenetic, Bone Morphogenetic Protein Market
1/--pages
Report inappropriate content